Sanofi (SNY) Earnings Date, Estimates & Call Transcripts $47.75 +1.00 (+2.15%) As of 03:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sanofi Earnings Summary Sanofi issued Q2 2025 earnings on July 31, 2025, reporting an EPS of $0.90, which missed analysts' consensus estimates of $0.96 by $0.06. Quarterly revenue fell 7.0% year-over-year to $11.34 billion, above the consensus estimate of $9.91 billion. With a trailing EPS of $4.16 and a P/E Ratio of 11.48, Sanofi's earnings are expected to grow 8.94% next year, from $4.36 to $4.75 per share. Latest Q2 Earnings DateJul. 31EstimatedConsensus EPS (Jul. 31) $0.96 Actual EPS (Jul. 31) $0.90 Missed By -$0.06 Actual Revenue (Jul. 31) $11.34BQ2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release Slide Deck Interim ReportSlide DeckFull Screen Slide DeckPowered by Get Sanofi Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sanofi and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSNY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SNY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Sanofi Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252$0.85$0.88$0.87Q2 20252$0.94$0.95$0.95Q3 20252$1.57$1.77$1.67Q4 20252$0.78$0.82$0.80 FY 2025 8 $4.14 $4.42 $4.28 Q1 20261$1.07$1.07$1.07Q2 20261$1.13$1.13$1.13Q3 20261$1.31$1.31$1.31Q4 20261$1.21$1.21$1.21 FY 2026 4 $4.72 $4.72 $4.72 Q1 20271$1.16$1.16$1.16Q2 20271$1.29$1.29$1.29 Sanofi Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails7/31/2025Q2 2025$0.96$0.90 -$0.06$1.84$9.91B$11.34B4/24/2025Q1 2025$0.90$0.94+$0.04$0.80$9.79B$10.41B1/30/2025Q4 2024$0.70$0.70-$0.29$10.57B-10/25/2024Q3 2024$0.22$1.57+$1.35$1.91$16.59B$13.44B7/25/2024Q2 2024$0.88$0.93+$0.05$1.38$16.86B$10.75B4/25/2024Q1 2024$0.96$0.96-$1.43$11.75B$11.36B2/1/2024Q4 2023$0.94$0.89 -$0.05$2.02$13.02B$11.76B10/27/2023Q3 2023$1.37$1.39+$0.02$1.67$13.61B$13.02B Sanofi Earnings - Frequently Asked Questions When did Sanofi announce their last quarterly earnings? Sanofi (NASDAQ:SNY) last announced its quarterly earning data on Thursday, July 31, 2025. Learn more on SNY's earnings history. Did Sanofi beat their earnings estimates last quarter? In the previous quarter, Sanofi (NASDAQ:SNY) missed the analysts' consensus estimate of $0.96 by $0.06 with a reported earnings per share (EPS) of $0.90. Learn more on analysts' earnings estimate vs. SNY's actual earnings. How can I listen to Sanofi's earnings conference call? The conference call for Sanofi's latest earnings report can be listened to online. Listen to Conference Call How can I read Sanofi's conference call transcript? The conference call transcript for Sanofi's latest earnings report can be read online. Read Transcript How much revenue does Sanofi generate each year? Sanofi (NASDAQ:SNY) has a recorded annual revenue of $44.46 billion. How much profit does Sanofi generate each year? Sanofi (NASDAQ:SNY) has a recorded net income of $6.02 billion. SNY has generated $2.80 earnings per share over the last four quarters. What is Sanofi's price-to-earnings ratio? Sanofi (NASDAQ:SNY) has a trailing price-to-earnings ratio of 11.34 and a forward price-to-earnings ratio of 10.82. The price/earnings-to-growth ratio is 1.12. What is Sanofi's EPS forecast for next year? Sanofi's earnings are expected to grow from $4.36 per share to $4.75 per share in the next year, which is a 8.94% increase. More Earnings Resources from MarketBeat Related Companies NVO Earnings NVS Earnings AZN Earnings GSK Earnings TAK Earnings ARGX Earnings ONC Earnings BNTX Earnings SMMT Earnings INSM Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Why Robinhood Just Added Upside Potential After a Q2 Earnings DipMicrosoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead? This page (NASDAQ:SNY) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.